Baxter Bros Inc’s Boston Scientific BSX Stock Holding History

Baxter Bros Inc’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$256K	Sell	4,075 -35	-0.9%	-$2.8K	0.03%	151
2025 Q4	$392K	Hold	4,110	–	–	0.05%	123
2025 Q3	$401K	Hold	4,110	–	–	0.05%	125
2025 Q2	$441K	Buy	4,110 +40	+1%	+$4.05K	0.05%	112
2025 Q1	$411K	Hold	4,070	–	–	0.05%	116
2024 Q4	$364K	Hold	4,070	–	–	0.05%	120
2024 Q3	$341K	Hold	4,070	–	–	0.04%	128
2024 Q2	$313K	Buy	4,070 +25	+0.6%	+$1.83K	0.04%	128
2024 Q1	$277K	Buy	4,045 +33	+0.8%	+$2.12K	0.04%	131
2023 Q4	$232K	Buy	+4,012	New	+$214K	0.03%	143

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Baxter Bros Inc's BSX Position: Q1 2026 in Review

Baxter Bros Inc reduced its Boston Scientific (BSX) stake by 0.85% in Q1 2026, selling an estimated $2.8K and leaving 4,075 shares worth $256K. The position accounts for 0.03% of the portfolio, ranked #151.

Baxter Bros Inc first reported a position in BSX in Q4 2023 and has held it in 10 quarters since. The position peaked at $441K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Baxter Bros Inc held 4,075 shares of Boston Scientific worth $256K as of Q1 2026.
Baxter Bros Inc sold 35 Boston Scientific shares in Q1 2026, an estimated $2.8K.
Boston Scientific made up 0.03% of Baxter Bros Inc's portfolio in Q1 2026, its #151 holding.
Baxter Bros Inc first reported a position in Boston Scientific in Q4 2023 and has held it in 10 quarters since.
Baxter Bros Inc's Boston Scientific position peaked at $441K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Baxter Bros Inc's 13F filing for Q1 2026, filed 28 Apr 2026.